{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:15:38Z","timestamp":1778944538502,"version":"3.51.4"},"reference-count":200,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["RD\/0119-ICMR000-001"],"award-info":[{"award-number":["RD\/0119-ICMR000-001"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["RD\/0120-ICMR000-002"],"award-info":[{"award-number":["RD\/0120-ICMR000-002"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.pharmthera.2022.108109","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T02:44:15Z","timestamp":1641523455000},"page":"108109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Genetic alterations and oxidative stress in T cell lymphomas"],"prefix":"10.1016","volume":"236","author":[{"given":"Sushant","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavuk","family":"Dhamija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diksha","family":"Attrish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinanti","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manju","family":"Sengar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayashree","family":"Thorat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanuja","family":"Shet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasmukh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Purwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2022.108109_bb0005","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1073\/pnas.1608839114","article-title":"Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas","volume":"114","author":"Abate","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/pcmr.12352","article-title":"Melanoma tumors frequently acquire LRP2\/megalin expression, which modulates melanoma cell proliferation and survival rates","volume":"28","author":"Andersen","year":"2015","journal-title":"Pigment Cell & Melanoma Research"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0015","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin\u2019s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"9","author":"Anderson","year":"1998","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030702","article-title":"STAT3 Mutation Is Associated with STAT3 Activation in CD30(+) ALK(-) ALCL","volume":"12","author":"Andersson","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0025","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/sj.jid.5700800","article-title":"Differential expression of TRAF1 aids in the distinction of cutaneous CD30-positive lymphoproliferations","volume":"127","author":"Assaf","year":"2007","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0030","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1073\/pnas.0611732104","article-title":"Importance of culturing primary lymphocytes at physiological oxygen levels","volume":"104","author":"Atkuri","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0035","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1128\/MCB.18.12.6951","article-title":"Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity","volume":"18","author":"Bai","year":"1998","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0040","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1530\/JME-11-0004","article-title":"Anaplastic lymphoma kinase in human cancer","volume":"47","author":"Barreca","year":"2011","journal-title":"Journal of Molecular Endocrinology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0045","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0050","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1083\/jcb.200609074","article-title":"The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production","volume":"177","author":"Bell","year":"2007","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0055","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bcp.2005.10.044","article-title":"Redox modifications of protein-thiols: emerging roles in cell signaling","volume":"71","author":"Biswas","year":"2006","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0060","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1042\/BST20140087","article-title":"Mitochondria and redox homoeostasis as chemotherapeutic targets","volume":"42","author":"Briehl","year":"2014","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0065","article-title":"Mitochondrial dynamics, ROS, and cell signaling: A blended overview","volume":"11","author":"Brillo","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0070","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1365-2141.2000.02174.x","article-title":"p53 allele deletion and protein accumulation occurs in the absence of p53 gene mutation in T-prolymphocytic leukaemia and Sezary syndrome","volume":"110","author":"Brito-Babapulle","year":"2000","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0075","first-page":"1466","article-title":"A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis","volume":"46","author":"Butzmann","year":"2020","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0080","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0085","doi-asserted-by":"crossref","first-page":"8438","DOI":"10.1158\/0008-5472.CAN-09-2367","article-title":"Identification of key regions and genes important in the pathogenesis of sezary syndrome by combining genomic and expression microarrays","volume":"69","author":"Caprini","year":"2009","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0090","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1002\/eji.1830251212","article-title":"Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo","volume":"25","author":"Castedo","year":"1995","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0095","doi-asserted-by":"crossref","first-page":"19585","DOI":"10.1074\/jbc.M111451200","article-title":"Reactive oxygen species differentially affect T cell receptor-signaling pathways","volume":"277","author":"Cemerski","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0898-6568(98)00025-4","article-title":"Oxidant, mitochondria and calcium: an overview","volume":"11","author":"Chakraborti","year":"1999","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.canlet.2014.11.031","article-title":"Plumbagin induces apoptosis in lymphoma cells via oxidative stress mediated glutathionylation and inhibition of mitogen-activated protein kinase phosphatases (MKP1\/2)","volume":"357","author":"Checker","year":"2015","journal-title":"Cancer Letters"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0115","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0120","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1182\/blood-2007-08-109074","article-title":"Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression","volume":"111","author":"Contassot","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Couronne","year":"2012","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0130","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.freeradbiomed.2005.02.019","article-title":"S-glutathionylation in human platelets by a thiol-disulfide exchange-independent mechanism","volume":"38","author":"Dalle-Donne","year":"2005","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0135","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1182\/blood.V87.8.3437.bloodjournal8783437","article-title":"The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin","volume":"87","author":"DeCoteau","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020432","article-title":"Mitochondrial calcium regulation of redox signaling in cancer","volume":"9","author":"Delierneux","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0145","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1523-1747.2002.01794.x","article-title":"Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin","volume":"118","author":"Dereure","year":"2002","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0150","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1046\/j.1365-2133.2000.03889.x","article-title":"Decreased expression of Fas (APO-1\/CD95) on peripheral blood CD4+ T lymphocytes in cutaneous T-cell lymphomas","volume":"143","author":"Dereure","year":"2000","journal-title":"The British Journal of Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0155","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1007\/s10495-017-1394-y","article-title":"Novel combination of salinomycin and resveratrol synergistically enhances the anti-proliferative and pro-apoptotic effects on human breast cancer cells","volume":"22","author":"Dewangan","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0160","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.freeradbiomed.2016.04.198","article-title":"Mitochondrial ROS regulation of proliferating cells","volume":"100","author":"Diebold","year":"2016","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0165","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1158\/0008-5472.CAN-08-3719","article-title":"The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease","volume":"70","author":"Dierks","year":"2010","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0170","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","article-title":"Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin","volume":"102","author":"Dobay","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0175","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1158\/0008-5472.CAN-04-1253","article-title":"Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis","volume":"64","author":"van Doorn","year":"2004","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0180","first-page":"5389","article-title":"A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphoma","volume":"62","author":"van Doorn","year":"2002","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0185","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1182\/blood-2008-04-153031","article-title":"Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome","volume":"113","author":"van Doorn","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0190","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1200\/JCO.2005.11.353","article-title":"Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73","volume":"23","author":"van Doorn","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0195","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jaci.2007.01.003","article-title":"Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells","volume":"119","author":"Ebner","year":"2007","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0200","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1097\/PAS.0b013e3181f32168","article-title":"Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role","volume":"34","author":"Espinosa","year":"2010","journal-title":"The American Journal of Surgical Pathology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0205","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.freeradbiomed.2010.08.024","article-title":"H2O2-induced mitochondrial fragmentation in C2C12 myocytes","volume":"49","author":"Fan","year":"2010","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0210","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1158\/1078-0432.CCR-13-1453","article-title":"Decitabine induces delayed reactive oxygen species (ROS) accumulation in leukemia cells and induces the expression of ROS generating enzymes","volume":"20","author":"Fandy","year":"2014","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0215","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0220","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/PAI.0000000000000683","article-title":"High-throughput sequencing of subcutaneous panniculitis-like T-cell lymphoma reveals candidate pathogenic mutations","volume":"27","author":"Fernandez-Pol","year":"2019","journal-title":"Applied Immunohistochemistry & Molecular Morphology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0225","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/PAI.0000000000000644","article-title":"A survey of somatic mutations in 41 genes in a cohort of T-cell lymphomas identifies frequent mutations in genes involved in epigenetic modification","volume":"27","author":"Fernandez-Pol","year":"2019","journal-title":"Applied Immunohistochemistry & Molecular Morphology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1083\/jcb.201102095","article-title":"Signal transduction by reactive oxygen species","volume":"194","author":"Finkel","year":"2011","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0235","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/35041687","article-title":"Oxidants, oxidative stress and the biology of ageing","volume":"408","author":"Finkel","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0240","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.hoc.2016.11.008","article-title":"Mycosis fungoides and sezary syndrome","volume":"31","author":"Foss","year":"2017","journal-title":"Hematology\/Oncology Clinics of North America"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0245","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.0022-202X.2004.23607.x","article-title":"Differential production of Th1- and Th2-type chemokines by mouse Langerhans cells and splenic dendritic cells","volume":"124","author":"Fujita","year":"2005","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0250","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/leu.2008.191","article-title":"High-resolution analysis of chromosome copy number alterations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, with single nucleotide polymorphism-typing microarrays","volume":"22","author":"Fujiwara","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0255","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41588-018-0251-4","article-title":"Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome","volume":"50","author":"Gayden","year":"2018","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0260","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41588-018-0304-8","article-title":"Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome","volume":"51","author":"Gayden","year":"2019","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0265","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMra032810","article-title":"The pathogenesis of mycosis fungoides","volume":"350","author":"Girardi","year":"2004","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0270","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2011-06-360321","article-title":"Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9","volume":"119","author":"Gleason","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0275","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/MCB.22.2.400-411.2002","article-title":"Effect of redox balance alterations on cellular localization of LAT and downstream T-cell receptor signaling pathways","volume":"22","author":"Gringhuis","year":"2002","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0280","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1089\/ars.2009.2728","article-title":"Hydrogen peroxide as a cell-survival signaling molecule","volume":"11","author":"Groeger","year":"2009","journal-title":"Antioxidants & Redox Signaling"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0285","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1196\/annals.1354.003","article-title":"Free radical theory of aging: an update: increasing the functional life span","volume":"1067","author":"Harman","year":"2006","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0290","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","article-title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma","volume":"133","author":"Heavican","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0295","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1074-7613(00)80072-2","article-title":"Reactive oxygen species regulate activation-induced T cell apoptosis","volume":"10","author":"Hildeman","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0300","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nri2476","article-title":"GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation","volume":"9","author":"Ho","year":"2009","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0305","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrm3801","article-title":"Cellular mechanisms and physiological consequences of redox-dependent signalling","volume":"15","author":"Holmstrom","year":"2014","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0310","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1210\/en.2007-0988","article-title":"Reactive oxygen species-mediated pancreatic beta-cell death is regulated by interactions between stress-activated protein kinases, p38 and c-Jun N-terminal kinase, and mitogen-activated protein kinase phosphatases","volume":"149","author":"Hou","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0315","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.clml.2016.10.001","article-title":"Analysis of peripheral T-cell lymphoma diagnostic workup in the United States","volume":"17","author":"Hsi","year":"2017","journal-title":"Clinical Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0320","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.cell.2013.11.020","article-title":"Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation","volume":"155","author":"Hu","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0325","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.semcancer.2017.04.005","article-title":"Mitochondrial ROS control of cancer","volume":"47","author":"Idelchik","year":"2017","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0330","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s12185-016-1973-7","article-title":"Roles of IDH1\/2 and TET2 mutations in myeloid disorders","volume":"103","author":"Inoue","year":"2016","journal-title":"International Journal of Hematology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0335","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.blre.2015.08.003","article-title":"Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?","volume":"30","author":"Iqbal","year":"2016","journal-title":"Blood Reviews"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0340","doi-asserted-by":"crossref","first-page":"C1176","DOI":"10.1152\/ajpcell.00017.2014","article-title":"Oxidative stress-induced mitochondrial fragmentation and movement in skeletal muscle myoblasts","volume":"306","author":"Iqbal","year":"2014","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0345","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1515\/BC.2006.174","article-title":"Aspects of the biological redox chemistry of cysteine: from simple redox responses to sophisticated signalling pathways","volume":"387","author":"Jacob","year":"2006","journal-title":"Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0350","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1158\/1535-7163.MCT-17-0060","article-title":"Decitabine priming enhances mucin 1 inhibition mediated disruption of redox homeostasis in cutaneous T-cell lymphoma","volume":"16","author":"Jain","year":"2017","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0355","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1200\/JCO.2008.19.9919","article-title":"Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I\/II melanoma","volume":"27","author":"Jensen","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0360","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1007\/s11033-020-05435-1","article-title":"Role of PI3K\/AKT pathway in cancer: the framework of malignant behavior","volume":"47","author":"Jiang","year":"2020","journal-title":"Molecular Biology Reports"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0365","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1158\/1078-0432.CCR-06-0171","article-title":"Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1","volume":"12","author":"Juarez","year":"2006","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0370","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2003.132","article-title":"Thymus and activation-regulated chemokine (TARC\/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides","volume":"48","author":"Kakinuma","year":"2003","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0898-6568(98)00037-0","article-title":"Redox regulation of cellular signalling","volume":"11","author":"Kamata","year":"1999","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0380","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cell.2004.12.041","article-title":"Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases","volume":"120","author":"Kamata","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0385","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2133.2007.08427.x","article-title":"Potential involvement of Notch1 signalling in the pathogenesis of primary cutaneous CD30-positive lymphoproliferative disorders","volume":"158","author":"Kamstrup","year":"2008","journal-title":"The British Journal of Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0390","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000108320","article-title":"Molecular cytogenetics in the study of cutaneous T-cell lymphomas (CTCL)","volume":"118","author":"Karenko","year":"2007","journal-title":"Cytogenetic and Genome Research"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0395","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1084\/jem.20021726","article-title":"Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma","volume":"197","author":"Kari","year":"2003","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0400","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0405","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature18294","article-title":"Aberrant PD-L1 expression through 3'-UTR disruption in multiple cancers","volume":"534","author":"Kataoka","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0410","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jaad.2012.12.952","article-title":"Follicular lymphomatoid papulosis revisited: a study of 11 cases, with new histopathological findings","volume":"68","author":"Kempf","year":"2013","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0415","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1158\/1535-7163.MCT-12-0141","article-title":"Oxidative stress induced by curcumin promotes the death of cutaneous T-cell lymphoma (HuT-78) by disrupting the function of several molecular targets","volume":"11","author":"Khan","year":"2012","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0420","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.1038\/ncomms9470","article-title":"Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sezary syndrome","volume":"6","author":"Kiel","year":"2015","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0425","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbrc.2008.06.007","article-title":"Glutathionylation regulates IkappaB","volume":"373","author":"Kil","year":"2008","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0430","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI24826","article-title":"Immunopathogenesis and therapy of cutaneous T cell lymphoma","volume":"115","author":"Kim","year":"2005","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0435","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.freeradbiomed.2003.12.010","article-title":"Superoxide dismutases in malignant cells and human tumors","volume":"36","author":"Kinnula","year":"2004","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0440","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.4161\/cc.24987","article-title":"STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma","volume":"12","author":"Kopp","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0445","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/nrc2761","article-title":"Mucins in cancer: function, prognosis and therapy","volume":"9","author":"Kufe","year":"2009","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0450","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1158\/1541-7786.MCR-19-0894","article-title":"The Th9 Axis Reduces the Oxidative Stress and Promotes the Survival of Malignant T Cells in Cutaneous T-Cell Lymphoma Patients","volume":"18","author":"Kumar","year":"2020","journal-title":"Molecular Cancer Research"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0455","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.jss.2009.05.026","article-title":"Significance of M2-polarized tumor-associated macrophage in pancreatic cancer","volume":"167","author":"Kurahara","year":"2011","journal-title":"The Journal of Surgical Research"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0460","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.redox.2018.08.014","article-title":"Identification of a functional antioxidant response element at the HIF1A locus","volume":"19","author":"Lacher","year":"2018","journal-title":"Redox Biology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0465","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.exger.2007.05.004","article-title":"Oxidative stress modulation and T cell activation","volume":"42","author":"Larbi","year":"2007","journal-title":"Experimental Gerontology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0470","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2013.02.003","article-title":"The copper chelator ATN-224 induces peroxynitrite-dependent cell death in hematological malignancies","volume":"60","author":"Lee","year":"2013","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0475","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0480","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/CCO.0000000000000474","article-title":"New insights in the pathogenesis of T-cell lymphomas","volume":"30","author":"Lemonnier","year":"2018","journal-title":"Current Opinion in Oncology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0485","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2141.2009.08003.x","article-title":"Advances in the understanding and management of angioimmunoblastic T-cell lymphoma","volume":"148","author":"de Leval","year":"2010","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0490","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/bjh.14611","article-title":"Recurrent mutations in epigenetic modifiers and the PI3K\/AKT\/mTOR pathway in subcutaneous panniculitis-like T-cell lymphoma","volume":"181","author":"Li","year":"2018","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003613","article-title":"Mitochondrial fusion is increased by the nuclear coactivator PGC-1beta","volume":"3","author":"Liesa","year":"2008","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108109_bb0500","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/mco2.16","article-title":"Mitochondria as a target in cancer treatment","volume":"2020","author":"Liu","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0505","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1091\/mbc.e07-07-0633","article-title":"The human spindle assembly checkpoint protein Bub3 is required for the establishment of efficient kinetochore-microtubule attachments","volume":"19","author":"Logarinho","year":"2008","journal-title":"Molecular Biology of the Cell"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0510","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13023-014-0160-2","article-title":"Molecular characterization of subcutaneous panniculitis-like T-cell lymphoma reveals upregulation of immunosuppression- and autoimmunity-associated genes","volume":"9","author":"Maliniemi","year":"2014","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0515","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cbi.2017.12.028","article-title":"Ascorbyl stearate and ionizing radiation potentiate apoptosis through intracellular thiols and oxidative stress in murine T lymphoma cells","volume":"281","author":"Mane","year":"2018","journal-title":"Chemico-Biological Interactions"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0520","doi-asserted-by":"crossref","first-page":"16124","DOI":"10.18632\/oncotarget.24592","article-title":"Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features","volume":"9","author":"Manso","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0525","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1182\/blood-2002-08-2434","article-title":"Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas","volume":"101","author":"Mao","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0530","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20032229","article-title":"Protein kinase C theta is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses","volume":"200","author":"Marsland","year":"2004","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160686","article-title":"PI-103 and Quercetin Attenuate PI3K-AKT Signaling Pathway in T- Cell Lymphoma Exposed to Hydrogen Peroxide","volume":"11","author":"Maurya","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0540","doi-asserted-by":"crossref","first-page":"8886","DOI":"10.1158\/0008-5472.CAN-10-0171","article-title":"Ionizing radiation activates the Nrf2 antioxidant response","volume":"70","author":"McDonald","year":"2010","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0545","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1182\/blood-2014-11-611194","article-title":"Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides","volume":"126","author":"McGirt","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0550","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1523-1747.1999.00507.x","article-title":"Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas","volume":"112","author":"McGregor","year":"1999","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0555","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aag2588","article-title":"Stress-induced dynamic regulation of mitochondrial STAT3 and its association with cyclophilin D reduce mitochondrial ROS production","volume":"10","author":"Meier","year":"2017","journal-title":"Science Signaling"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0560","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fonc.2020.00514","article-title":"New Insights Into the Complex Mutational Landscape of Sezary Syndrome","volume":"10","author":"Mirza","year":"2020","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0565","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/1346-8138.12305","article-title":"Immunological milieu in mycosis fungoides and Sezary syndrome","volume":"41","author":"Miyagaki","year":"2014","journal-title":"The Journal of Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0570","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00403-012-1238-0","article-title":"Angiogenin levels are increased in lesional skin and sera in patients with erythrodermic cutaneous T cell lymphoma","volume":"304","author":"Miyagaki","year":"2012","journal-title":"Archives of Dermatological Research"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0575","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/415536a","article-title":"Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease","volume":"415","author":"Monney","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0580","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma","volume":"263","author":"Morris","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0585","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/blood-2015-06-644948","article-title":"Variegated RHOA mutations in adult T-cell leukemia\/lymphoma","volume":"127","author":"Nagata","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0590","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1084\/jem.20140987","article-title":"Gain-of-function CCR4 mutations in adult T cell leukemia\/lymphoma","volume":"211","author":"Nakagawa","year":"2014","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0595","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.4161\/15384101.2014.965061","article-title":"Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression","volume":"13","author":"Netchiporouk","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0600","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.122","article-title":"Identification of cell-type-specific mutations in nodal T-cell lymphomas","volume":"7","author":"Nguyen","year":"2017","journal-title":"Blood Cancer Journal"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0605","first-page":"123","article-title":"Effect of hydrogen peroxide on proliferation, apoptosis and interleukin-2 production of Jurkat T cells","volume":"40","author":"Nindl","year":"2004","journal-title":"Biomedical Sciences Instrumentation"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0610","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s12185-016-2159-z","article-title":"BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma","volume":"105","author":"Nishizawa","year":"2017","journal-title":"International Journal of Hematology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0615","doi-asserted-by":"crossref","first-page":"38388","DOI":"10.1074\/jbc.M105395200","article-title":"Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu,Zn-SOD in mitochondria","volume":"276","author":"Okado-Matsumoto","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0620","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0625","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PAS.0000000000000555","article-title":"Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features","volume":"40","author":"Ondrejka","year":"2016","journal-title":"The American Journal of Surgical Pathology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0630","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10815-016-0654-z","article-title":"The poly(A)-binding protein genes, EPAB, PABPC1, and PABPC3 are differentially expressed in infertile men with non-obstructive azoospermia","volume":"33","author":"Ozturk","year":"2016","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0635","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0640","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood-2017-02-768234","article-title":"Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E)","volume":"130","author":"Park","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0645","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0650","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2016-12-755496","article-title":"DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study","volume":"130","author":"Pedersen","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0655","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/his.14005","article-title":"Fluorescence in-situ hybridisation for TP63 rearrangements in T cell lymphomas: single-site experience of 470 patients and implications for clinical testing","volume":"76","author":"Peterson","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0660","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/jid.2011.9","article-title":"Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated","volume":"131","author":"Pettersen","year":"2011","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0665","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/jid.2009.314","article-title":"IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases","volume":"130","author":"Pham-Ledard","year":"2010","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0670","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1182\/bloodadvances.2018028340","article-title":"Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma","volume":"3","author":"Polprasert","year":"2019","journal-title":"Blood Advances"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0675","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jid.2016.03.024","article-title":"Identification of gene mutations and fusion genes in patients with sezary syndrome","volume":"136","author":"Prasad","year":"2016","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0680","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s00018-004-4275-9","article-title":"The emerging normal and disease-related roles of anaplastic lymphoma kinase","volume":"61","author":"Pulford","year":"2004","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0685","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/cup.12446","article-title":"ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient","volume":"42","author":"Pulitzer","year":"2015","journal-title":"Journal of Cutaneous Pathology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0690","first-page":"574","article-title":"Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options","volume":"24","author":"Querfeld","year":"2010","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0695","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1182\/blood-2006-07-036368","article-title":"IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia\/lymphoma","volume":"109","author":"Ramos","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0700","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1101\/gad.276568.115","article-title":"Role of TET enzymes in DNA methylation, development, and cancer","volume":"30","author":"Rasmussen","year":"2016","journal-title":"Genes & Development"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0705","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1126\/science.1130481","article-title":"Cell signaling. H2O2, a necessary evil for cell signaling","volume":"312","author":"Rhee","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0710","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0047-6374(02)00120-3","article-title":"Oxidative inactivation of CD45 protein tyrosine phosphatase may contribute to T lymphocyte dysfunction in the elderly","volume":"124","author":"Rider","year":"2003","journal-title":"Mechanisms of Ageing and Development"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0715","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2015.357","article-title":"Recurrent activating mutations of CD28 in peripheral T-cell lymphomas","volume":"30","author":"Rohr","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0720","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/bjh.17211","article-title":"Clinical significance of CD28 gene-related activating alterations in adult T-cell leukaemia\/lymphoma","volume":"192","author":"Sakamoto","year":"2021","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0725","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0730","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/jid.2009.306","article-title":"Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides","volume":"130","author":"Salgado","year":"2010","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0735","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/jid.2014.487","article-title":"MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma","volume":"135","author":"Sandoval","year":"2015","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0740","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3324\/haematol.2010.028605","article-title":"Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia\/lymphoma as a target for epigenetic therapy","volume":"96","author":"Sasaki","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0745","doi-asserted-by":"crossref","first-page":"9717530","DOI":"10.1155\/2016\/9717530","article-title":"Sezary syndrome and atopic dermatitis: comparison of immunological aspects and targets","volume":"2016","author":"Saulite","year":"2016","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0750","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Current Biology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0755","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2016-02-694455","article-title":"No TP63 rearrangements in a selected group of primary cutaneous CD30+ lymphoproliferative disorders with aggressive clinical course","volume":"128","author":"Schrader","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0760","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molcel.2012.09.025","article-title":"Physiological roles of mitochondrial reactive oxygen species","volume":"48","author":"Sena","year":"2012","journal-title":"Molecular Cell"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0765","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood.V96.1.307","article-title":"Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis","volume":"96","author":"Shacter","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0770","first-page":"2194","article-title":"Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin\/anaplastic lymphoma kinase-mediated lymphomagenesis","volume":"61","author":"Slupianek","year":"2001","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0775","first-page":"1058","article-title":"HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma","volume":"135","author":"Sonigo","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0780","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ni805","article-title":"Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP","volume":"3","author":"Soumelis","year":"2002","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0785","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1749-6632.2000.tb06199.x","article-title":"Glucose deprivation-induced oxidative stress in human tumor cells. A fundamental defect in metabolism?","volume":"899","author":"Spitz","year":"2000","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0790","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s41379-019-0254-4","article-title":"The pathological features of angioimmunoblastic T-cell lymphomas with IDH2(R172) mutations","volume":"32","author":"Steinhilber","year":"2019","journal-title":"Modern Pathology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0795","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1600-0560.1997.tb01090.x","article-title":"The t(2;5)-associated p80 NPM\/ALK fusion protein in nodal and cutaneous CD30+ lymphoproliferative disorders","volume":"24","author":"Su","year":"1997","journal-title":"Journal of Cutaneous Pathology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0800","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2340\/00015555-1428","article-title":"Association of nerve growth factor, chemokine (C-C motif) ligands and immunoglobulin E with pruritus in cutaneous T-cell lymphoma","volume":"93","author":"Suga","year":"2013","journal-title":"Acta Dermato-Venereologica"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0805","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jid.2018.02.028","article-title":"SATB1 Defines a Subtype of Cutaneous CD30(+) Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine Profile","volume":"138","author":"Sun","year":"2018","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0810","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0815","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003004","article-title":"Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1","volume":"2","author":"Thome","year":"2010","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0820","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1073\/pnas.1101795108","article-title":"Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer","volume":"108","author":"Tili","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0825","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood-2011-08-374371","article-title":"Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan","volume":"119","author":"Tokunaga","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0830","article-title":"Exercise and Mitochondrial Dynamics: Keeping in Shape with ROS and AMPK","volume":"7","author":"Trewin","year":"2018","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0835","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.leukres.2005.10.012","article-title":"Additional Her 2\/neu gene copies in patients with Sezary syndrome","volume":"30","author":"Utikal","year":"2006","journal-title":"Leukemia Research"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0840","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0845","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","article-title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas","volume":"128","author":"Vallois","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0850","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0855","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2007.03.016","article-title":"Hydrogen peroxide sensing and signaling","volume":"26","author":"Veal","year":"2007","journal-title":"Molecular Cell"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0860","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1158\/0008-5472.CAN-07-6398","article-title":"Novel and highly recurrent chromosomal alterations in Sezary syndrome","volume":"68","author":"Vermeer","year":"2008","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0865","first-page":"5508","article-title":"High steady-state levels of p53 are not a prerequisite for tumor eradication by wild-type p53-specific cytotoxic T lymphocytes","volume":"60","author":"Vierboom","year":"2000","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0870","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/1523-1747.ep12611877","article-title":"Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells","volume":"99","author":"Vowels","year":"1992","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0875","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","article-title":"Mitochondria and Cancer","volume":"166","author":"Vyas","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0880","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/ng.3444","article-title":"Genomic profiling of Sezary syndrome identifies alterations of key T cell signaling and differentiation genes","volume":"47","author":"Wang","year":"2015","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0885","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/s41375-019-0473-1","article-title":"Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling","volume":"33","author":"Watatani","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0890","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/s41375-019-0473-1","article-title":"Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling","volume":"33","author":"Watatani","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0895","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1749-6632.2001.tb03709.x","article-title":"Molecular genetics of cutaneous lymphomas","volume":"941","author":"Whittaker","year":"2001","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0900","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.2174\/138161211796957463","article-title":"gamma-Tocotrienol induces apoptosis in human T cell lymphoma through activation of both intrinsic and extrinsic pathways","volume":"17","author":"Wilankar","year":"2011","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0905","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0910","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0915","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/nature07844","article-title":"Embryonic stem cells use ZFP809 to silence retroviral DNAs","volume":"458","author":"Wolf","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0920","first-page":"51","article-title":"TP53 gene status affects survival in advanced mycosis fungoides","volume":"3","author":"Wooler","year":"2016","journal-title":"Frontiers of Medicine (Lausanne)"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0925","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/jid.2008.309","article-title":"Low FAS\/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation","volume":"129","author":"Wu","year":"2009","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0930","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archdermatol.2010.376","article-title":"Reduction of Fas\/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma","volume":"147","author":"Wu","year":"2011","journal-title":"Archives of Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0935","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/jid.2009.45","article-title":"Cutaneous T-cell lymphoma: roles for chemokines and chemokine receptors","volume":"129","author":"Wu","year":"2009","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0940","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.bbrc.2015.12.059","article-title":"Pyrvinium selectively induces apoptosis of lymphoma cells through impairing mitochondrial functions and JAK2\/STAT5","volume":"469","author":"Xiao","year":"2016","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0945","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/01.pas.0000213267.92349.59","article-title":"Chemokine receptor expression in cutaneous T cell and NK\/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay","volume":"30","author":"Yagi","year":"2006","journal-title":"The American Journal of Surgical Pathology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0950","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/path.5376","article-title":"Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell","volume":"250","author":"Yao","year":"2020","journal-title":"The Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0955","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3324\/haematol.2015.139253","article-title":"Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma","volume":"101","author":"Yoo","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0960","first-page":"13","article-title":"Clinical applications of genomic alterations in ATLL: predictive markers and therapeutic targets","author":"Yoshida","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0965","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuint.2009.03.001","article-title":"The human GLUD2 glutamate dehydrogenase: localization and functional aspects","volume":"55","author":"Zaganas","year":"2009","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0970","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.onc.1205152","article-title":"Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death","volume":"21","author":"Zamo","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0975","first-page":"4576","article-title":"Quinalizarin induces ROSmediated apoptosis via the MAPK, STAT3 and NFkappaB signaling pathways in human breast cancer cells","volume":"20","author":"Zang","year":"2019","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0980","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3389\/fonc.2018.00679","article-title":"Aspirin Inhibits Natural Killer\/T-Cell Lymphoma by Modulation of VEGF Expression and Mitochondrial Function","volume":"8","author":"Zhang","year":"2018","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0985","first-page":"3","article-title":"Mitochondrial electron transport chain, ROS generation and uncoupling (Review)","volume":"44","author":"Zhao","year":"2019","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0990","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/s41422-018-0090-y","article-title":"Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis","volume":"28","author":"Zhou","year":"2018","journal-title":"Cell Research"},{"key":"10.1016\/j.pharmthera.2022.108109_bb0995","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1182\/blood-2010-10-310425","article-title":"Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia","volume":"117","author":"Zhou","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108109_bb1000","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiological Reviews"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822000031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822000031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:23:54Z","timestamp":1759011834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725822000031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":200,"alternative-id":["S0163725822000031"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108109","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic alterations and oxidative stress in T cell lymphomas","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108109"}}